|
Transporter Symbol |
Disease |
|
4F2HC, SLC3A2 |
Lysinuria |
|
ABC-1, ABC1 |
Tangiers disease |
|
ABC7, hABC7 |
X-linked sideroblastic anemia |
|
ABCR |
Stargardt disease, Fundus flavimaculatus |
|
AE1, SLC4A1 |
elliptocytosis, ovalocytosis, hemolytic anemia, spherocytosis, renal tubular acidosis |
|
AE2, SLC4A2 |
congenital chloroidorrhea |
|
AE3, SLC4A3 |
congenital chloroidorrhea |
|
ALDR |
Adrenoleukodystrophy |
|
ANK |
ankylosis (calcification); arthritis accompanied by mineral deposition, formation of bony outgrowths, and joint destruction |
|
Aralar-like, SLC25A13 |
adult-onset type II citrullinemia |
|
ATBo, SLC1A5, hATBo, ASCT2, AAAT |
Neurodegeneration |
|
BCMP1, UCP4, SLC25A14 |
HHH |
|
CFTR |
Cystic fibrosis |
|
CTR-1, SLC31A1 |
Menkes/Wilsons disease |
|
CTR-2, SLC31A2 |
Menkes/Wilsons disease, X-linked hypophosphatemia |
|
DTD, SLC26A2 |
chondrodysplasias/ diadtrophic dysplasia |
|
EAAT1, SLC1A3, GLAST1 |
Neurodegeneration, Amyotrophic lateral sclerosis |
|
EAAT2, SLC1A2, GLT-1 |
Neurodegeneration, Dicarboxylic aminoaciduria |
|
EAAT3, SLC1A1, EAAC1 |
Neurodegeneration |
|
EAAT4, SLC1A6 |
Neurodegeneration |
|
EAAT5, SLC1A7 |
Neurodegeneration |
|
FIC1 |
Progressive familial intrahepatic cholestasis |
|
FOLT, SLC19A1, RFC1 |
Folate malabsorption/megaloblastic anemia |
|
GLUT1, SLC2A1 |
low CNS glucose causing seizures, Fanconi-Bickel syndrome, Glycogen storage disease type Id, Non-insulin-dependent diabetes mellitus, defect in glucose transport across the blood-brain barrier |
|
GLUT2, SLC2A2 |
low CNS glucose causing seizures, Fanconi-Bickel syndrome, Glycogen storage disease type Id, Non-insulin-dependent diabetes mellitus (NIDDM) |
|
GLUT3, SLC2A3 |
low CNS glucose causing seizures, Fanconi-Bickel syndrome, Glycogen storage disease type Id, Non-insulin-dependent diabetes mellitus (NIDDM) |
|
GLUT4, SLC2A4 |
low CNS glucose causing seizures, Fanconi-Bickel syndrome, Glycogen storage disease type Id, Non-insulin-dependent diabetes mellitus (NIDDM) |
|
GLUT5, SLC2A5 |
Isolated fructose malabsorption |
|
HET |
anemia, genetic hemochromatosis |
|
HTT, SLC6A4 |
anxiety-related traits |
|
LAT-2, SLC7A6 |
Lysinuric protein intolerance |
|
LAT-3, SLC7A7 |
lysinuric protein intolerance |
|
MDR1 |
human cancers |
|
MDR2, MDR3 |
Familia intrahepatic cholestasis |
|
MRP1 |
human cancers |
|
NBC |
Down's syndrome |
|
NBC1, SLC4A4 |
renal tubular acidosis |
|
NBC3, SLC4A7 |
congenital hypothyroidism |
|
NCCT, SLC12A3, TSC |
Gitelman syndrome |
|
NHE2, SLC9A2 |
Microvillus inclusion disease |
|
NHE3, SLC9A3/3P |
Microvillus inclusion disease |
|
NIS, SLC5A5 |
congenital hypothyroidism |
|
NKCC1, SLC12A2 |
gitelman's syndrome |
|
NKCC2, SLC12A1 |
Bartter's syndrome |
|
NORTR |
DiGeorge syndrome, velocardiofacial syndrome |
|
NRAMP2, DCT1, SLC11A2, |
attention-deficit disorder |
|
NTCP2, ISBT, SLC10A2 |
primary bile acid malabsorption (PBAM) |
|
OCTN2, SLC22A5 |
systemic carnitine deficiency (progressive cardiomyopathy, skeletal myopathy, hypoglycaemia, hyperammonaemia, sudden infant death syndrome) |
|
ORNT1, SLC25A15 |
HHH |
|
PMP34, SLC25A17 |
Graves' disease |
|
rBAT, SLC3A1, D2 |
cystinuria |
|
SATT, SLC1A4, ASCT1 |
Neurodegeneration |
|
SBC2 |
hypocitraturia |
|
SERT |
various mental disorders |
|
SGLT1, SLC5A1 |
renal glucosuria / glucose-galactose malabsorption |
|
SGLT2, SLC5A2 |
renal glucosuria |
|
SMVT, SLC5A6 |
anxiety-related traits, depression |
|
TAP1 |
juvenile onset psriasis |
|
y+L |
Type I ystinuria |
Transporter Disease data entry by: Qing Yan, Mahrokh Jamshidi